VOJTECHOVA, Gabriela, Ondřej NGO, Tomas GREGA, Klara KMOCHOVA, Michal VOSKA, Barbora BUČKOVÁ, Ondřej MÁJEK, Miroslav ZAVORAL and Stepan SUCHANEK. The conversion factor for predicting adenoma detection rate from polyp detection rate varies according to colonoscopy indication and patient sex. European Journal of Cancer Prevention. Philadelphia: Lippincott Williams & Wilkins, 2020, vol. 29, No 4, p. 294-302. ISSN 0959-8278. Available from: https://dx.doi.org/10.1097/CEJ.0000000000000558.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name The conversion factor for predicting adenoma detection rate from polyp detection rate varies according to colonoscopy indication and patient sex
Authors VOJTECHOVA, Gabriela (203 Czech Republic), Ondřej NGO (203 Czech Republic, belonging to the institution), Tomas GREGA (203 Czech Republic), Klara KMOCHOVA (203 Czech Republic), Michal VOSKA (203 Czech Republic), Barbora BUČKOVÁ (703 Slovakia, belonging to the institution), Ondřej MÁJEK (203 Czech Republic, belonging to the institution), Miroslav ZAVORAL and Stepan SUCHANEK (203 Czech Republic, guarantor).
Edition European Journal of Cancer Prevention, Philadelphia, Lippincott Williams & Wilkins, 2020, 0959-8278.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.497
RIV identification code RIV/00216224:14110/20:00118612
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1097/CEJ.0000000000000558
UT WoS 000545919600003
Keywords in English adenoma detection rate; adenoma to polyp detection rate quotient; colonoscopy; conversion factor; linear regression coefficient; performance measures; polyp detection rate
Tags 14119612, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 3/8/2020 13:25.
Abstract
The adenoma detection rate (ADR) is the primary quality indicator for colonoscopies. The polyp detection rate (PDR) is available from administrative data and does not depend on histology verification. The correlation between PDR and ADR and the ADR/PDR conversion factor in preventive colonoscopies were evaluated. In the prospective study, asymptomatic individuals aged 45-75 years with preventive colonoscopy in 2012-2016 were included. Spearman's correlation coefficient was used to assess PDR/ADR for each endoscopist. Conversion factor predicting ADR from PDR was obtained by linear regression and subsequently compared with adenoma to polyp detection rate quotient. One thousand six hundred fourteen preventive colonoscopies performed by 16 endoscopists in 8 screening colonoscopy centres in the Czech Republic were analysed. Correlation between PDR and ADR in all preventive colonoscopies was high and statistically significant (Rs 0.82;P< 0.001). There was a strong correlation between PDR and ADR in men (Rs 0.74;P= 0.002) and in screening colonoscopies (Rs 0.85;P< 0.001). The conversion factor to convert ADR from PDR was 0.72 in all preventive colonoscopies, 0.76 in FOBT+ colonoscopies and 0.67 in screening colonoscopies. ADR may be replaced by PDR in the assessment of colonoscopy quality. The value of the conversion factor varies according to colonoscopy indication and gender of examined individuals; in this Czech study, it was 0.72 in all preventive colonoscopies. The minimum requested ADR of 25 % corresponds to a PDR of 35 %, when converted with the appropriate conversion factor.
Links
NV16-29614A, research and development projectName: Porovnání účinnosti kolonické kapslové endoskopie a optické kolonoskopie u osob s pozitivním imunochemickým testem na okultní krvácení do stolice
NV17-31909A, research and development projectName: Vývoj multiparametrického testu nové generace pro predikci rizika rekurence kolorektální neoplázie
NV18-08-00246, research and development projectName: Endoskopická transmurální resekce versus standardní endoskopická terapie v léčbě kolorektální neoplázie – prospektivní randomizovaná studie
Investor: Ministry of Health of the CR
PrintDisplayed: 10/8/2024 05:26